Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Intrahepatic biliary strictures after liver transplantation are morphologically similar to primary sclerosing cholangitis but immunologically distinct.

Zhou T, Bartelheimer K, Ruping F, Rupp C, Sauer P, Koschny R, Mehrabi A, Mieth M, von Haken R, Weiss KH, Gotthardt DN, Rauber C.

Eur J Gastroenterol Hepatol. 2020 Feb;32(2):276-284. doi: 10.1097/MEG.0000000000001649.

PMID:
31895887
2.

Shedding light on the interaction of hydrocarbon ester substituents upon formation of dimeric titanium(IV) triscatecholates in DMSO solution.

Kwamen C, Schlottmann M, VanCraen D, Isaak E, Baums J, Shen L, Massomi A, Räuber C, Joseph B, Raabe G, Göb C, Oppel I, Puttreddy R, Ward J, Rissanen K, Fröhlich R, Albrecht M.

Chemistry. 2019 Nov 18. doi: 10.1002/chem.201904639. [Epub ahead of print]

PMID:
31737953
3.

Prevalence of human herpesviruses in biliary fluid and their association with biliary complications after liver transplantation.

Rauber C, Bartelheimer K, Zhou T, Rupp C, Schnitzler P, Schemmer P, Sauer P, Weiss KH, Gotthardt DN.

BMC Gastroenterol. 2019 Jun 27;19(1):110. doi: 10.1186/s12876-019-1033-x.

4.

Kinetic investigation of the dissociation of dinuclear hierarchically assembled titanium(iv) helicates.

Van Craen D, Schlottmann M, Stahl W, Räuber C, Albrecht M.

Dalton Trans. 2019 Jul 16;48(28):10574-10580. doi: 10.1039/c9dt01065c.

PMID:
31215927
5.

Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are associated with biliary damage and graft survival in a case-control study.

Rauber C, Awad M, Koschny R, Sauer P, Mehrabi A, Gath P, Weiss KH, Gotthardt DN, Rupp C.

Clin Res Hepatol Gastroenterol. 2019 Jun 11. pii: S2210-7401(19)30102-0. doi: 10.1016/j.clinre.2019.05.005. [Epub ahead of print]

PMID:
31201006
6.

From One-Pot NH-Sulfoximidations of Thiophene Derivatives to Dithienylethene-Type Photoswitches.

Verbelen B, Siemes E, Ehnbom A, Räuber C, Rissanen K, Wöll D, Bolm C.

Org Lett. 2019 Jun 7;21(11):4293-4297. doi: 10.1021/acs.orglett.9b01475. Epub 2019 May 23.

PMID:
31120764
7.

A Helicate-Based Three-State Molecular Switch.

Chen X, Gerger TM, Räuber C, Raabe G, Göb C, Oppel IM, Albrecht M.

Angew Chem Int Ed Engl. 2018 Sep 3;57(36):11817-11820. doi: 10.1002/anie.201806607. Epub 2018 Aug 6.

PMID:
30027682
8.

Impact of age at diagnosis on disease progression in patients with primary sclerosing cholangitis.

Rupp C, Rössler A, Zhou T, Rauber C, Friedrich K, Wannhoff A, Weiss KH, Sauer P, Schirmacher P, Süsal C, Stremmel W, Gotthardt DN.

United European Gastroenterol J. 2018 Mar;6(2):255-262. doi: 10.1177/2050640617717156. Epub 2017 Jun 17.

9.

Hypercalcemia, necrotizing pancreatitis and bone lesions: a benign cause.

Rauber C, Kihm L, Merle U.

Clin Cases Miner Bone Metab. 2017 May-Aug;14(2):245-246. doi: 10.11138/ccmbm/2017.14.2.245. Epub 2017 Oct 25.

10.

Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.

Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, Iribarren K, Mondragón L, Jacquelot N, Qu B, Ferrere G, Clémenson C, Mezquita L, Masip JR, Naltet C, Brosseau S, Kaderbhai C, Richard C, Rizvi H, Levenez F, Galleron N, Quinquis B, Pons N, Ryffel B, Minard-Colin V, Gonin P, Soria JC, Deutsch E, Loriot Y, Ghiringhelli F, Zalcman G, Goldwasser F, Escudier B, Hellmann MD, Eggermont A, Raoult D, Albiges L, Kroemer G, Zitvogel L.

Science. 2018 Jan 5;359(6371):91-97. doi: 10.1126/science.aan3706. Epub 2017 Nov 2.

PMID:
29097494
11.

Chasing Weak Forces: Hierarchically Assembled Helicates as a Probe for the Evaluation of the Energetics of Weak Interactions.

Van Craen D, Rath WH, Huth M, Kemp L, Räuber C, Wollschläger JM, Schalley CA, Valkonen A, Rissanen K, Albrecht M.

J Am Chem Soc. 2017 Nov 22;139(46):16959-16966. doi: 10.1021/jacs.7b10098. Epub 2017 Nov 8.

PMID:
29068687
12.

Von Willebrand factor and alkaline phosphatase predict re-transplantation-free survival after the first liver transplantation.

Wannhoff A, Rauber C, Friedrich K, Rupp C, Stremmel W, Weiss KH, Schemmer P, Gotthardt DN.

United European Gastroenterol J. 2017 Feb;5(1):86-93. doi: 10.1177/2050640616650060. Epub 2016 Jul 8.

13.

TLR activation and ionizing radiation induce strong immune responses against multiple tumor entities.

Schölch S, Rauber C, Weitz J, Koch M, Huber PE.

Oncoimmunology. 2015 May 7;4(11):e1042201. eCollection 2015 Nov.

14.

Palladium/Copper-Cocatalyzed Oxidative Amidobrominations of Alkenes.

Chen XY, Bohmann RA, Wang L, Dong S, Räuber C, Bolm C.

Chemistry. 2015 Jul 13;21(29):10330-3. doi: 10.1002/chem.201501629. Epub 2015 Jun 17.

PMID:
26139012
15.

Copper- and Vanadium-Catalyzed Oxidative Cleavage of Lignin using Dioxygen.

Mottweiler J, Puche M, Räuber C, Schmidt T, Concepción P, Corma A, Bolm C.

ChemSusChem. 2015 Jun 22;8(12):2106-13. doi: 10.1002/cssc.201500131. Epub 2015 May 26.

PMID:
26013592
16.

Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors.

Schölch S, Rauber C, Tietz A, Rahbari NN, Bork U, Schmidt T, Kahlert C, Haberkorn U, Tomai MA, Lipson KE, Carretero R, Weitz J, Koch M, Huber PE.

Oncotarget. 2015 Mar 10;6(7):4663-76.

17.

Solvent-dependent enthalpic versus entropic anion binding by biaryl substituted quinoline based anion receptors.

Sun ZH, Albrecht M, Raabe G, Pan FF, Räuber C.

J Phys Chem B. 2015 Jan 8;119(1):301-6. doi: 10.1021/jp510796f. Epub 2014 Dec 17.

PMID:
25516141
18.

Analysis of selected and designed chimeric D- and L-α-helix assemblies.

Kükenshöner T, Hagemann UB, Wohlwend D, Räuber C, Baumann T, Keller S, Einsle O, Müller KM, Arndt KM.

Biomacromolecules. 2014 Sep 8;15(9):3296-305. doi: 10.1021/bm5006883. Epub 2014 Aug 13.

PMID:
25072521
19.

Characterization and inhibition of AF10-mediated interaction.

Hagen S, Mattay D, Räuber C, Müller KM, Arndt KM.

J Pept Sci. 2014 Jun;20(6):385-97. doi: 10.1002/psc.2626. Epub 2014 Apr 1.

PMID:
24692230
20.

TAT hitchhiker selection expanded to folding helpers, multimeric interactions and combinations with protein fragment complementation.

Speck J, Räuber C, Kükenshöner T, Niemöller C, Mueller KJ, Schleberger P, Dondapati P, Hecky J, Arndt KM, Müller KM.

Protein Eng Des Sel. 2013 Mar;26(3):225-42. doi: 10.1093/protein/gzs098. Epub 2012 Dec 6.

PMID:
23223941
21.
22.

13C-NMR detection of STD spectra.

Räuber C, Berger S.

Magn Reson Chem. 2010 Feb;48(2):91-3. doi: 10.1002/mrc.2558.

PMID:
20024889
23.

Selection of peptides interfering with protein-protein interaction.

Gaida A, Hagemann UB, Mattay D, Räuber C, Müller KM, Arndt KM.

Methods Mol Biol. 2009;535:263-91. doi: 10.1007/978-1-59745-557-2_16.

PMID:
19377990
24.

HIPAA compliance: electronic claims processing.

Rauber C.

Healthplan. 2004 Mar-Apr;45(2):32-4. No abstract available.

PMID:
15079973
25.

Supporting informed choice. Health insurers provide a growing range of tools.

Rauber C.

Healthplan. 2004 Jan-Feb;45(1):20-4. No abstract available.

PMID:
14994659
26.
27.

Communities try to reclaim hospitals.

Moore JD Jr, Rauber C.

Mod Healthc. 1999 Sep 27;29(39):20. No abstract available.

PMID:
10621433
28.

1999 up & comers.

Jaklevic MC, Taylor M, Rauber C, Shinkman R, Morrissey J, Moore JD Jr, Saphir A, Kirchheimer B, Bellandi D.

Mod Healthc. 1999 Sep 13;29(37):46-8, 50, 52-64.

PMID:
10621402
29.

Making a recovery. With premiums rising and medical costs under control, HMOs are looking a lot healthier.

Rauber C.

Mod Healthc. 1999 Oct 11;29(41):50. No abstract available.

PMID:
10623223
30.

Health plans trim aid for prescription drugs.

Rauber C.

Mod Healthc. 1999 Oct 4;29(40):26. No abstract available.

PMID:
10621447
31.

Compromise saves money-losing PHO.

Rauber C.

Mod Healthc. 1999 Sep 13;29(37):2-3. No abstract available.

PMID:
10621393
33.

Audit: UCSF Stanford deal added to losses.

Rauber C.

Mod Healthc. 1999 Sep 6;29(36):20. No abstract available.

PMID:
10558267
34.
35.
36.

States target plans exiting Medicare.

Rauber C.

Mod Healthc. 1999 Aug 23;29(34):20-1. No abstract available.

PMID:
10557473
37.

Aetna's Prudential buy has strings attached.

Rauber C.

Mod Healthc. 1999 Aug 16;29(33):10. No abstract available.

PMID:
10557457
38.
39.

Battle is brewing over HMO premium dollars.

Rauber C.

Mod Healthc. 1999 Jul 12;29(28):50. No abstract available.

PMID:
10538630
40.

HIV treatment data soon to be on Web.

Rauber C.

Mod Healthc. 1999 Jul 12;29(28):24. No abstract available.

PMID:
10538626
41.

Clock ticks for Aetna to sell Texas plans.

Rauber C.

Mod Healthc. 1999 Jun 28;29(26):18-9. No abstract available.

PMID:
10538610
42.

Group Health to drop coverage for 21,000.

Rauber C.

Mod Healthc. 1999 Jun 21;29(25):88. No abstract available.

PMID:
10538607
43.

Medicaid HMOs exit markets. Shrinking pool of managed-care plans could mean lower reimbursement to provider.

Saphir A, Rauber C.

Mod Healthc. 1999 Jun 21;29(25):46, 48. No abstract available.

PMID:
10538598
44.
45.

PPOs riding a wave of popularity.

Rauber C.

Mod Healthc. 1999 Jun 7;29(23):50, 55. No abstract available.

PMID:
10537923
46.

Medicare-risk retreats. Cigna to exit six HMO urban markets; Humana slows marketing.

Rauber C.

Mod Healthc. 1999 May 17;29(20):3, 17. No abstract available.

PMID:
10387870
47.

Drug wars. Health plans blast Calif. regulators for requiring them to retain medications on their formularies.

Rauber C.

Mod Healthc. 1999 May 10;29(19):74. No abstract available.

PMID:
10387863
48.

Premium jumps boost managed-care giants.

Rauber C.

Mod Healthc. 1999 May 10;29(19):24-5. No abstract available.

PMID:
10387855
49.

Laying blame. GAO faults managed-care plans for Medicare problems; plans disagree, predict more pullouts.

Rauber C.

Mod Healthc. 1999 May 3;29(18):7. No abstract available.

PMID:
10387849
50.

Mass. Blues goes public with R.I. bid.

Rauber C.

Mod Healthc. 1999 Apr 26;29(17):12. No abstract available.

PMID:
10351818

Supplemental Content

Loading ...
Support Center